Study Design. The micro-computed tomography (micro-CT) was applied to assess the effect of tetramethylpyrazine (TMP) on experimental spinal cord injury (SCI).
S
pinal cord injury (SCI) is a devastating event and is the major cause of the loss of sensation and mobility in patients, and poses a heavy burden to people's health worldwide. 1 Numerous therapeutic interventions have been investigated and have demonstrated promotion of neurological function recovery after SCI. 2, 3 Unfortunately, no effective methods have shown a dramatically improved neurological function outcome in clinical practice.
Currently, SCI treatment relies upon methylprednisolone injection. The administration of methylprednisolone for acute SCI treatment may, however, lead to various unacceptable side effects for patients, and its efficacy and clinical impact on SCI recovery are also controversial. [4] [5] [6] A novel therapeutic approach to enhance neurological function recovery after SCI with fewer side effects should be promoted.
SCI is always accompanied by severe injury to the function and structure of microvessels, which causes regional microcirculation obstruction and can enhance the secondary injury cascade after SCI. 7, 8 Previous investigations have demonstrated that the blood supply to the central nervous system can provide nutritional support to the neuroparenchyma that is essential for local tissue survival and repair. 9 , 10 Bearden and Segal's 11 research also revealed that the vessel may serve as guidance for axonal sprouting after an injury. Thus, to promote angiogenesis and maximally improving local vascular perfusion to the injured spinal cord parenchyma would be an ideal therapeutic intervention to enhance the recovery of neurological function after SCI.
Tetramethylpyrazine (TMP; C 8 H 12 N 2, molecular weight, 136.2) is one of the most important active ingredients extracted from the Chinese herbal medicine plant Chuan Xiong. 12 It has the capability to effectively traverse into the central nervous system through the blood-brain barrier, and has been widely used in the treatment of ischemic stroke disease. [13] [14] [15] [16] [17] [18] [19] Our previous research also reveals that TMP can accelerate functional recovery in traumatic spinal cords by inhibiting the development of inflammation. 20 In spite of these potential roles of TMP in treatment, the underlying mechanisms by which it protects against central nervous system ischemic disease have, however, not been thoroughly investigated.
Previous research on the morphology change of vessel during SCI process relied on the tissue section and immunofluorescence staining. 21 This approach provides only twodimensional information of the vessel. Micro-computed tomography (micro-CT) developed recent years and has been recognized as a powerful method to detect the threedimensional (3D) structure of the bio-sample. 22, 23 In this study, we used micro-CT to track the 3D morphology changes of the spinal cord microvasculature after injury and to investigate the therapeutic effect of TMP on angiogenesis during this process.
MATERIALS AND METHODS

Animals
Adult male Sprague-Dawley rats (Central South University Animal Center, Changsha, China), weighing 250 to 300 g, were used in this experiment. All experimental procedures were approved by the Ethics Committee of Central South University. All efforts were made to minimize both the number of animals used and the suffering of the animals. All animals were housed in individual cages in a temperature-and light cycle-controlled environment with free access to food and water.
Contusion Spinal Cord Injury Model
The rats underwent a T10 contusive SCI using the modified Allen's impact method. Briefly, the rats were anesthetized with an intraperitoneal injection of 10% chloral hydrate (3 mg/kg). A laminectomy was performed at vertebral level T10. The exposed spinal cord was subjected to a moderate vertical impact load using a modified Allen's weight drop apparatus (8 g weight at a vertical height of 40 mm).
Experimental Design
The rats were randomly divided into three groups: (1) sham group, in which rats received the same surgical procedures but sustained no impact injury; (2) control group, in which rats were subjected to SCI and were treated intraperitoneally with saline (200 mg/kg); and (3) TMP group, in which rats were subjected to SCI and treated intraperitoneally with TMP (200 mg/kg), every 24 hours for 5 days, starting half an hour after contusion SCI. Parameter measurements and animal number at the specific time points with different tools are listed in Table 1 .
Neurological Function Assessment
The hindlimb functions were evaluated by the Basso-Beattie-Bresnahan (BBB) locomotor scale method, which ranges from 0 to 21. 24 BBB scores were recorded at 1, 3, 7, 14, 21, and 28 days after injury by two independent investigators in a blinded manner. The final score for each animal was obtained by calculating the average value from both investigators.
Lesion Area Measurement
The spinal cord lesion volume was assessed by Cresyl Violet staining as described previously. 25 After fixation, the tissue blocks were embedded in paraffin. Every 40th paraffin transection with 6 mm thickness, including the lesion site, was stained in 0.5% Cresyl Violet acetate solution for 2 minutes and imaged using a microscope (BH-2; Olympus, NY). After SCI, the integrity of the specimen will be destroyed and the lesion areas were outlined and measured using Image-Pro Plus 6.0 (Media Cybernetics) software. Transverse sections, with an interval of 400 mm rostral and caudal to the lesion epicenter, were analyzed up to a distance of 1600 mm away from the lesion epicenter.
Immunofluorescence Staining
At the time of euthanasia, the animals were perfused as described above. Then, spinal cord tissue was harvested at the specific time point and was fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS; pH 7.4) at room temperature for 3 hours, followed by cryoprotection with 6% sucrose/PBS overnight, rinsing with acetone, and embedding in optimal cutting temperature compound (Sakura Finetek) for 10-mm-thick sections. The sections were then blocked with 10% goat serum that was diluted in PBS for 1 hour to block nonspecific binding, followed by incubation with a mouse monoclonal RECA-1 antibody in PBS overnight at 48C. After washing in PBS three times, the sections were incubated with secondary antibodies, Alexa Fluor 488 goat anti-rabbit IgG (H þ L) (1:1000, Jackson) and Cy3 goat antimouse IgG (H þ L) (1:1000, Jackson), and diluted in 3% goat serum for 30 minutes at room temperature. The sections were washed with PBS followed by counterstaining with DAPI and were then mounted using an antifade mounting medium. We selected the slides from the injury epicenter and examined the tissues with an Olympus BX51 Microscope (Olympus America). The cells were costained with PCNA/RECA-1 to indicate vessel proliferation. The cell stain with RECA-1 means vessel existed. The numbers of positively stained cells in five random visual fields (100 mm Â 100 mm) of the anterior horn of gray matter in one spinal cord section per rat were counted for each group.
Micro-CT Scanning and Microvascular Morphometric Assessment
The spinal cord was subjected to micro-CT examination after an intracardiac injection of Microfil. Briefly, all animals at 1, 7, 14, and 28 days after injury were anesthetized with an intraperitoneal injection of 10% chloral hydrate (3 mg/kg). Then, a thoracotomy was rapidly performed to expose the heart. Heparinized saline was rapidly and sufficiently perfused into the circulatory system via the ascending aorta, allowing an effective drain of blood flow. Then, 10% buffered formalin was perfused for vessel network fixation. The components of yellow contrast agent (Microfil MV-122, Flow Tech, CA) were mixed and continually infused into the rat ascending aorta via a perfusion pump. Thereafter, all animals were preserved in a refrigerator at 48C to cure overnight. The next day, a 5-mm-long T10 thoracic cord segment was harvested and fixed in a 10% buffered formalin solution. The next day, a 5-mm-long segment of the spinal cord centered at the injury epicenter was harvested and prepared for 3D visualization of the microvasculature by a micro-CT (Explore Locus SP, GE Healthcare) apparatus according to a previously described procedure. 26 After sample scanning, the micro-CT visualization and analysis software package MicroView 2.1.2 (GE Healthcare) was used for vascular morphology analysis according to a previously reported method. 26 Briefly, we conducted the following protocol for vascular morphological parameter measurement: (1) Vectorization, a skeletonization based on voxel erosin plugin in software was used to automatically extract the centerline of the vessel; (2) Once the centerline has been successfully extracted, the quantification of parameters of the vascular network such as vessel numbers, vessel volume fraction (VVF), and vessel connectivity for each segment was systematically analyzed. The VVF represents the ratio between the numbers of vessels belonging to a vasculature compared with the total number of vessels in the biological tissue. Vessel connectivity value (VCV) was determined as the maximal number of branches before the vessel structure splits into two parts, which was conducted to provide information about 3D appearance of the vessel branches.
Statistical Analysis
All experimental data analyses were performed using SPSS 17.0 software (The University of Cambridge, UK). Data values are presented as the mean AE SD and have normal distribution. The significance of differences in histological and micro-CT values between the control and TMP groups at specific time points was analyzed using Student t test. The BBB scores between groups were analyzed by the Wilcoxon rank sum test. A P value of less than 0.05 was interpreted to be statistically significant.
RESULTS
Tetramethylpyrazine Promotes Neurological Function After Spinal Cord Injury
The hindlimb functions were measured by the BBB scoring system and are shown in Figure 1 . No neurological impairment symptoms were detected in the sham group. After SCI, the hindlimb functions of all rats in the control and TMP groups were incompletely paralyzed. Then, a spontaneous functional recovery of the locomotor activity after SCI in both groups was detected during the evaluation period. The hindlimb locomotor activity improved gradually, and the BBB scores increased in both groups. Compared with the control group, neurological function recovery was significantly improved in the TMP group on day 7 after the injury. On day 28, the average BBB score of the NS group was 10.75 AE 0.884 and the TMP group was 14.5 AE 0.707. The rats in the TMP group, however, showed consistent plantar stepping and forelimbhindlimb coordination. In contrast, the rats in the control group showed no forelimb-hindlimb coordination and frequent to consistent weight-supported plantar steps.
Tetramethylpyrazine Reduced Spinal Cord Lesion Area
After the neurological function assessment, the lesion area of the spinal cord was examined using Cresyl Violet staining Figure 1 . Time course of neurological function recovery measured by the Basso-Beattie-Bresnahan score from 1 to 28 days after spinal cord injury. Hindlimb function was improved with treatment using TMP when compared with the control group.
Ã P < 0.05, comparing the TMP group with control group at the time points of 7, 14, 21, and 28 days after injury. BBB indicates Basso-Beattie-Bresnahan; TMP, tetramethylpyrazine.
at 28 days after injury. As shown in Figure 2 , the lesion area of the spinal cord in both groups was not only concentrated in the injury epicenter of the thoracic spinal cord, but it also extended rostrally and caudally from the epicenter (Figure 2A) . In groups treated with TMP, the spinal cord had reduced lesion area ( Figure 2B ) and maintained a larger spared tissue area ( Figure 2C ) compared with that observed in the control group.
Tetramethylpyrazine Enhances Spinal Cord InjuryInduced Angiogenesis
Fluorescent double labeling demonstrated that a greater number of PCNA/RECA-1 positive cells (yellow arrow) were detected in the TMP-treated group than in the control group at 7 days after injury, indicating the presence of proliferating vessel endothelial cells ( Figure 3A , B, and C). The number of vessel after injury was measured by RECA-1 immunofluorescence staining. The number of vessels was significantly increased in the TMP-treated group compared with that in the control group, and both are below the normal level of the sham group at 28 days after injury ( Figure 4A and B) .
Micro-CT Assessment of 3D Microvasculature Changes After Spinal Cord Injury
To monitor the 3D microvasculature morphology changes after SCI, micro-CT in combination with vascular contrast agent perfusion was employed in this examination. We successfully obtained the 3D morphology of the spinal cord microvasculature ( Figure 5A ). When trauma occurs, the vessels number (VN), VVF, and VCV in both groups significantly decrease (yellow arrow indicates the injured area), suggesting that injury induced traumatic damage to the spinal cord microvasculature ( Figure 5B and C), and then followed by gradually increased postinjury, revealing that there was a spontaneous process of angiogenesis induced by the acute trauma. When compared to the control group, the VN, VVF, and VCV were higher in TMP groups at 7, 14, and 28 days after injury, but both of them failed to reach the normal level at 28 days after injury.
DISCUSSION
SCI causes rapid disruption of the normal blood supply to the spinal cord because of direct physical injury to the microvessel. 7 It has been recognized that to promote angiogenesis, early reconstruction of the local microvasculature network and improvement of the vascular perfusion to the spinal cord can maximally enhance neurological function recovery after SCI.
In our present study, we find that treatment of the injured spinal cord with TMP can significantly promote the neurological function outcome when compared with the control group. The immunofluorescence and micro-CT data demonstrated that the microvessel density was also increased in the TMP treatment group, suggesting that TMP can promote local angiogenesis in the injured spinal cord. A previous study has reported that treatment with TMP following SCI provides neurological protection to the spinal cord by attenuating the inflammation reaction or antiapoptosis. 20 There has, however, been little known effect of TMP treatment in SCI on angiogenesis. In our current study, we first clarify the role of TMP on new vessel formation.
Previous research revealed that new microvessels may form after injury in the rat brain ischemia model at an adjacent area close to the damage epicenter in the early stages post-trauma. This process has been considered to be endogenous protection of vascularization to keep the injured neuronal cell from further damage. 25, 27 Casella et al 28 also reported that a temporary endogenous revascularization can occur within the first week of the SCI process, and it reached a peak at 7 days after injury. In our experiment, new vessel formation was gradually increased postinjury, suggesting that post angiogenesis existed and was consistent with previous study. 28 Unfortunately, this endogenous angiogenesis mechanism cannot provide a sufficient amount of repair for the injured neuronal tissue. After TMP treatment, we detected a larger lumber of endothelial proliferation (PCNA/RECA-1 positive cell) cell as early as 7 days postinjury compared with control groups (Figure 3 ). The data revealed that TMP can protect endothelial cells against ischemia and increase the proliferation, enhancing posttraumatic angiogenesis.
It has been reported that micro-CT is a powerful method for the 3D visualization of biological samples, and it has been widely used in different research fields. [29] [30] [31] In our previous experiment, we also successfully reconstructed the 3D morphology of the spinal cord microvasculature in the rat model using micro-CT in combination with the vascular contrast agent perfusion. 26 In order to characterize the 3D morphological changes of the spinal cord microvasculature after injury, the vascular morphological parameters including the VN, VVF, and VCV were employed. We find that the VN, VVF, and VCV were significantly increased in the TMP treatment group than in the control group at 7, 14, and 28 days after injury. These data are consistent with the histological method by immunostaining displayed in Figure 4 . Both of these results suggest that TMP can promote angiogenesis in the injured spinal cord after SCI. This is also our first time to conduct a comprehensive quantitative analysis of the vascular reaction and remodeling after the TMP treatment during SCI process by combining these two methods. And we successfully define the characteristics of microvessel morphology changes after SCI from two dimensions to three dimensions.
These data demonstrated that the application of micro-CT could serve as a powerful tool to evaluate the efficiency of therapeutic intervention targets on microvessel repair or regeneration. However, it still has some imaging limitations, for example, when the trauma-induced rupture of blood vessels or intramedullary occlusion occurs, the contrast agents may lead to leakage or result in incomplete perfusion, which directly affects the authenticity of the vascular morphometric parameter measurement. We optimize the perfusion procedure during the sample preparation, which has already been described in detail in our previous study. 26 Otherwise, developing an in vivo imaging technique for dynamically visualizing the alteration of the artery after injury or drug administration was expected to be a promising tool to learn the vascular reaction and deserves further investigation.
CONCLUSION
In our study, we presented that the injury-induced lesion area could be attenuated by treatment with TMP. Similarly, TMP can promote angiogenesis and restoring the blood supply to the neuroparenchyma; this might be a major reason that TMP can lead to better neurological function recovery following SCI. This finding suggests that TMP could be a promising therapeutic strategy for SCI treatment.
Key Points
Tetramethylpyrazine promotes neurological function recovery after spinal cord injury . Tetramethylpyrazine demonstrates neuroprotection after spinal cord injury. Tetramethylpyrazine enhances vessel endothelial cell proliferation and promotes angiogenesis after spinal cord injury Micro-CT is useful for detecting 3D microvessel changes in response to spinal cord injury. Ã P < 0.05 comparing the TMP groups with control groups at 7, 14, and 28 days after injury. Bar ¼ 500 mm. TMP indicates tetramethylpyrazine.
